Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/12/1010   
Active ingredient: Ataluren
Indication: Treatment of Becker muscular dystrophy
Sponsor: PTC Therapeutics, Limited
Lakeside House, Office G33a, 1 Furzeground Way, Stockley Park E. Uxbridge, UB11 1BD, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/07/2012 Orphan Designation EMA/OD/032/12 (2012)4775 of 04/07/2012
02/08/2013 Change of address of sponsor
05/08/2014 Change of address of sponsor